REGISTERED
on 26 Dec 2023
Last Applicant/ Owned by
MUENCHENSTEINERSTRASSE 38
BASEL
CH
CH-4052
Serial Number
97601016 filed on 21st Sep 2022
Registration Number
7256367 registered on 26th Dec 2023
Correspondent Address
Lawrence J. Crain
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
EXOASO-STAT6
EXOASO STAT SIX Pharmaceutical and biologic preparations for use in oncology and immuno-oncology; biological components being a component in therapeutic preparations, namely, engineered exosomes delivering antisense oligonucleotides to inhibit tumor growth and induce anti-tumor immune response; therapeutic agents for the treatment of cancer and immuno-oncological diseases; therapeutic agents for Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical and biologic preparations for use in oncology and immuno-oncology; biological components being a component in therapeutic preparations, namely, engineered exosomes delivering antisense oligonucleotides to inhibit tumor growth and induce anti-tumor immune response; therapeutic agents for the treatment of cancer and immuno-oncological diseases; therapeutic agents for inducing anti-tumor immune response
First Use Date in General
20th Feb 2023
First Use Date in Commerce
20th Feb 2023
Mark Details
Serial Number
No 97601016
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 153037
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Dec 2023 | REGISTERED-PRINCIPAL REGISTER |
| 26th Dec 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 21st Nov 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 20th Nov 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 17th Nov 2023 | SU - NON-FINAL ACTION - WRITTEN |
| 17th Nov 2023 | NON-FINAL ACTION E-MAILED |
| 17th Nov 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 16th Nov 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 09th Nov 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 30th Oct 2023 | TEAS STATEMENT OF USE RECEIVED |